Cart
sales@molnova.com
Alflutinib methanesulfonate
CAS No. 2130958-55-1
Alflutinib methanesulfonate ( AST2818;AST-2818;ASK120067 )
Catalog No. M13393 CAS No. 2130958-55-1
Alflutinib methanesulfonate (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 149 | In Stock |
|
| 10MG | 222 | In Stock |
|
| 25MG | 374 | In Stock |
|
| 50MG | 555 | In Stock |
|
| 100MG | 790 | In Stock |
|
| 500MG | 1611 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlflutinib methanesulfonate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlflutinib methanesulfonate (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.
-
DescriptionAlflutinib methanesulfonate (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor, inhibits EGFR active mutations as well as T790M acquired resistant mutation.Lung Cancer Phase 1 Clinical
-
SynonymsAST2818;AST-2818;ASK120067
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
IndicationLung Cancer
Chemical Information
-
CAS Number2130958-55-1
-
Formula Weight664.71
-
Molecular FormulaC29H35F3N8O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 5 mg/mL 7.52 mM
-
SMILESCN(C)CCN(C)c1nc(OCC(F)(F)F)c(Nc2nccc(n2)c3cn(C)c4ccccc34)cc1NC(=O)C=C.CS(=O)(=O)O
-
Chemical NameN-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide methanesulfonate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. PCT Int. Appl. (2017), WO 2017152707 A1 20170914.
2. PCT Int. Appl. (2017), WO 2017152706 A1 20170914.
2. PCT Int. Appl. (2017), WO 2017152706 A1 20170914.
molnova catalog
related products
-
Avitinib
Avitinib (AC-0010, AC0010) is an orally available, irreversible, and mutant-selective EGFR inhibitor with IC50 of 0.18 nM against EGFR L858R/T790M.
-
VUF 10166
VUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower.
-
Erlotinib mesylate
Erlotinib (CP-358774;OSI-774;NSC 718781) is a potent, selective inhibitor of EGFR with IC50 of 2 nM.
